nodes	percent_of_prediction	percent_of_DWPC	metapath
Flavoxate—PDE4D—hypertension	0.252	0.515	CbGaD
Flavoxate—PDE4A—hypertension	0.238	0.485	CbGaD
Flavoxate—Diphenidol—Bepridil—hypertension	0.162	1	CrCrCtD
Flavoxate—PDE8B—hindlimb—hypertension	0.00552	0.124	CbGeAlD
Flavoxate—CHRM1—Nicardipine—hypertension	0.00265	0.52	CbGbCtD
Flavoxate—CHRM2—Nicardipine—hypertension	0.00244	0.48	CbGbCtD
Flavoxate—PDE8A—cardiac ventricle—hypertension	0.00171	0.0385	CbGeAlD
Flavoxate—PDE7A—kidney—hypertension	0.00165	0.0373	CbGeAlD
Flavoxate—PDE8A—myocardium—hypertension	0.00161	0.0362	CbGeAlD
Flavoxate—PDE7B—heart—hypertension	0.00157	0.0353	CbGeAlD
Flavoxate—PDE4C—brainstem—hypertension	0.00133	0.0301	CbGeAlD
Flavoxate—PDE8B—heart—hypertension	0.00125	0.0281	CbGeAlD
Flavoxate—PDE8A—nephron tubule—hypertension	0.00118	0.0265	CbGeAlD
Flavoxate—PDE7B—adrenal gland—hypertension	0.00117	0.0263	CbGeAlD
Flavoxate—PDE8A—adrenal cortex—hypertension	0.00116	0.0261	CbGeAlD
Flavoxate—PDE7A—endocrine gland—hypertension	0.00116	0.0261	CbGeAlD
Flavoxate—PDE8A—heart—hypertension	0.00112	0.0253	CbGeAlD
Flavoxate—PDE8A—smooth muscle tissue—hypertension	0.00111	0.0251	CbGeAlD
Flavoxate—PDE8A—decidua—hypertension	0.00109	0.0246	CbGeAlD
Flavoxate—PDE7A—central nervous system—hypertension	0.00104	0.0235	CbGeAlD
Flavoxate—PDE4D—heart—hypertension	0.00102	0.0229	CbGeAlD
Flavoxate—PDE8A—cortex of kidney—hypertension	0.00101	0.0227	CbGeAlD
Flavoxate—PDE8A—cardiac atrium—hypertension	0.000959	0.0216	CbGeAlD
Flavoxate—PDE8B—adrenal gland—hypertension	0.00093	0.021	CbGeAlD
Flavoxate—PDE4D—cortex of kidney—hypertension	0.000914	0.0206	CbGeAlD
Flavoxate—PDE7B—central nervous system—hypertension	0.000913	0.0206	CbGeAlD
Flavoxate—PDE8A—medulla oblongata—hypertension	0.000904	0.0204	CbGeAlD
Flavoxate—PDE4A—heart—hypertension	0.000899	0.0203	CbGeAlD
Flavoxate—Raloxifene—HTR2B—hypertension	0.000878	0.298	CrCbGaD
Flavoxate—PDE4A—decidua—hypertension	0.000875	0.0197	CbGeAlD
Flavoxate—PDE8A—adrenal gland—hypertension	0.000837	0.0189	CbGeAlD
Flavoxate—PDE4B—cardiac ventricle—hypertension	0.000817	0.0184	CbGeAlD
Flavoxate—PDE8B—endocrine gland—hypertension	0.000807	0.0182	CbGeAlD
Flavoxate—PDE4B—myocardium—hypertension	0.000768	0.0173	CbGeAlD
Flavoxate—PDE4D—adrenal gland—hypertension	0.000758	0.0171	CbGeAlD
Flavoxate—PDE8B—central nervous system—hypertension	0.000727	0.0164	CbGeAlD
Flavoxate—Raloxifene—ESR2—hypertension	0.000682	0.231	CrCbGaD
Flavoxate—PDE4C—central nervous system—hypertension	0.000673	0.0152	CbGeAlD
Flavoxate—PDE4A—adrenal gland—hypertension	0.000671	0.0151	CbGeAlD
Flavoxate—Antrafenine—PTGS1—hypertension	0.000592	0.201	CrCbGaD
Flavoxate—PDE4B—heart—hypertension	0.000536	0.0121	CbGeAlD
Flavoxate—CHRM2—heart—hypertension	0.000533	0.012	CbGeAlD
Flavoxate—PDE4B—decidua—hypertension	0.000521	0.0117	CbGeAlD
Flavoxate—CHRM2—cardiovascular system—hypertension	0.000503	0.0113	CbGeAlD
Flavoxate—PDE4B—cortex of kidney—hypertension	0.000482	0.0109	CbGeAlD
Flavoxate—PDE4B—cardiac atrium—hypertension	0.000459	0.0103	CbGeAlD
Flavoxate—CHRM1—cardiovascular system—hypertension	0.000457	0.0103	CbGeAlD
Flavoxate—Raloxifene—CYP19A1—hypertension	0.000456	0.155	CrCbGaD
Flavoxate—PDE4B—medulla oblongata—hypertension	0.000432	0.00974	CbGeAlD
Flavoxate—PDE4B—adrenal gland—hypertension	0.0004	0.00902	CbGeAlD
Flavoxate—PDE4B—endocrine gland—hypertension	0.000347	0.00782	CbGeAlD
Flavoxate—CHRM2—endocrine gland—hypertension	0.000345	0.00777	CbGeAlD
Flavoxate—Antrafenine—PTGS2—hypertension	0.000338	0.115	CrCbGaD
Flavoxate—CHRM1—endocrine gland—hypertension	0.000314	0.00707	CbGeAlD
Flavoxate—PDE4B—central nervous system—hypertension	0.000313	0.00705	CbGeAlD
Flavoxate—CHRM2—central nervous system—hypertension	0.000311	0.007	CbGeAlD
Flavoxate—CHRM1—central nervous system—hypertension	0.000283	0.00637	CbGeAlD
Flavoxate—Palpitations—Captopril—hypertension	0.000164	0.0011	CcSEcCtD
Flavoxate—Confusional state—Clonidine—hypertension	0.000164	0.0011	CcSEcCtD
Flavoxate—Vomiting—Esmolol—hypertension	0.000164	0.00109	CcSEcCtD
Flavoxate—Somnolence—Nifedipine—hypertension	0.000164	0.00109	CcSEcCtD
Flavoxate—Vision blurred—Betaxolol—hypertension	0.000164	0.00109	CcSEcCtD
Flavoxate—Somnolence—Verapamil—hypertension	0.000163	0.00109	CcSEcCtD
Flavoxate—Nausea—Benazepril—hypertension	0.000163	0.00109	CcSEcCtD
Flavoxate—Nausea—Nadolol—hypertension	0.000162	0.00108	CcSEcCtD
Flavoxate—Vertigo—Perindopril—hypertension	0.000162	0.00108	CcSEcCtD
Flavoxate—Dry mouth—Trandolapril—hypertension	0.000162	0.00108	CcSEcCtD
Flavoxate—Vomiting—Terazosin—hypertension	0.000162	0.00108	CcSEcCtD
Flavoxate—Vertigo—Irbesartan—hypertension	0.000162	0.00108	CcSEcCtD
Flavoxate—Leukopenia—Perindopril—hypertension	0.000162	0.00108	CcSEcCtD
Flavoxate—Headache—Esmolol—hypertension	0.000162	0.00108	CcSEcCtD
Flavoxate—Dry mouth—Enalapril—hypertension	0.000161	0.00108	CcSEcCtD
Flavoxate—Leukopenia—Irbesartan—hypertension	0.000161	0.00108	CcSEcCtD
Flavoxate—Vertigo—Hydrochlorothiazide—hypertension	0.00016	0.00107	CcSEcCtD
Flavoxate—Nausea—Isradipine—hypertension	0.00016	0.00107	CcSEcCtD
Flavoxate—Leukopenia—Hydrochlorothiazide—hypertension	0.00016	0.00107	CcSEcCtD
Flavoxate—Vision blurred—Losartan—hypertension	0.00016	0.00107	CcSEcCtD
Flavoxate—Palpitations—Perindopril—hypertension	0.00016	0.00107	CcSEcCtD
Flavoxate—Confusional state—Enalapril—hypertension	0.00016	0.00107	CcSEcCtD
Flavoxate—Headache—Terazosin—hypertension	0.000159	0.00106	CcSEcCtD
Flavoxate—Nausea—Guanfacine—hypertension	0.000159	0.00106	CcSEcCtD
Flavoxate—Dry mouth—Telmisartan—hypertension	0.000159	0.00106	CcSEcCtD
Flavoxate—Feeling abnormal—Diltiazem—hypertension	0.000159	0.00106	CcSEcCtD
Flavoxate—Feeling abnormal—Indapamide—hypertension	0.000159	0.00106	CcSEcCtD
Flavoxate—Tachycardia—Clonidine—hypertension	0.000159	0.00106	CcSEcCtD
Flavoxate—Nausea—Nicardipine—hypertension	0.000159	0.00106	CcSEcCtD
Flavoxate—Urticaria—Propranolol—hypertension	0.000159	0.00106	CcSEcCtD
Flavoxate—Skin disorder—Clonidine—hypertension	0.000158	0.00106	CcSEcCtD
Flavoxate—Palpitations—Hydrochlorothiazide—hypertension	0.000158	0.00105	CcSEcCtD
Flavoxate—Vomiting—Acebutolol—hypertension	0.000158	0.00105	CcSEcCtD
Flavoxate—Vertigo—Furosemide—hypertension	0.000158	0.00105	CcSEcCtD
Flavoxate—Feeling abnormal—Carvedilol—hypertension	0.000158	0.00105	CcSEcCtD
Flavoxate—Leukopenia—Furosemide—hypertension	0.000157	0.00105	CcSEcCtD
Flavoxate—Nausea—Metolazone—hypertension	0.000157	0.00105	CcSEcCtD
Flavoxate—Nausea—Felodipine—hypertension	0.000157	0.00105	CcSEcCtD
Flavoxate—Nausea—Spironolactone—hypertension	0.000156	0.00104	CcSEcCtD
Flavoxate—Vomiting—Labetalol—hypertension	0.000156	0.00104	CcSEcCtD
Flavoxate—Vertigo—Betaxolol—hypertension	0.000156	0.00104	CcSEcCtD
Flavoxate—Feeling abnormal—Doxazosin—hypertension	0.000156	0.00104	CcSEcCtD
Flavoxate—Headache—Acebutolol—hypertension	0.000155	0.00104	CcSEcCtD
Flavoxate—Tachycardia—Trandolapril—hypertension	0.000155	0.00104	CcSEcCtD
Flavoxate—Dry mouth—Captopril—hypertension	0.000155	0.00103	CcSEcCtD
Flavoxate—Tachycardia—Enalapril—hypertension	0.000154	0.00103	CcSEcCtD
Flavoxate—Skin disorder—Trandolapril—hypertension	0.000154	0.00103	CcSEcCtD
Flavoxate—Headache—Labetalol—hypertension	0.000154	0.00103	CcSEcCtD
Flavoxate—Feeling abnormal—Fosinopril—hypertension	0.000154	0.00103	CcSEcCtD
Flavoxate—Palpitations—Betaxolol—hypertension	0.000154	0.00103	CcSEcCtD
Flavoxate—Urticaria—Diltiazem—hypertension	0.000153	0.00102	CcSEcCtD
Flavoxate—Urticaria—Indapamide—hypertension	0.000153	0.00102	CcSEcCtD
Flavoxate—Nausea—Esmolol—hypertension	0.000153	0.00102	CcSEcCtD
Flavoxate—Feeling abnormal—Eplerenone—hypertension	0.000153	0.00102	CcSEcCtD
Flavoxate—Confusional state—Captopril—hypertension	0.000153	0.00102	CcSEcCtD
Flavoxate—Tachycardia—Telmisartan—hypertension	0.000152	0.00102	CcSEcCtD
Flavoxate—Vertigo—Losartan—hypertension	0.000152	0.00102	CcSEcCtD
Flavoxate—Urticaria—Carvedilol—hypertension	0.000152	0.00101	CcSEcCtD
Flavoxate—Somnolence—Valsartan—hypertension	0.000152	0.00101	CcSEcCtD
Flavoxate—Feeling abnormal—Nifedipine—hypertension	0.000152	0.00101	CcSEcCtD
Flavoxate—Skin disorder—Telmisartan—hypertension	0.000152	0.00101	CcSEcCtD
Flavoxate—Leukopenia—Losartan—hypertension	0.000152	0.00101	CcSEcCtD
Flavoxate—Vomiting—Eprosartan—hypertension	0.000151	0.00101	CcSEcCtD
Flavoxate—Feeling abnormal—Verapamil—hypertension	0.000151	0.00101	CcSEcCtD
Flavoxate—Nausea—Terazosin—hypertension	0.000151	0.00101	CcSEcCtD
Flavoxate—Dry mouth—Perindopril—hypertension	0.00015	0.001	CcSEcCtD
Flavoxate—Urticaria—Doxazosin—hypertension	0.00015	0.001	CcSEcCtD
Flavoxate—Dry mouth—Irbesartan—hypertension	0.00015	0.001	CcSEcCtD
Flavoxate—Palpitations—Losartan—hypertension	0.00015	0.000999	CcSEcCtD
Flavoxate—Headache—Eprosartan—hypertension	0.000149	0.000996	CcSEcCtD
Flavoxate—Dry mouth—Hydrochlorothiazide—hypertension	0.000149	0.000992	CcSEcCtD
Flavoxate—Confusional state—Perindopril—hypertension	0.000149	0.000992	CcSEcCtD
Flavoxate—Urticaria—Fosinopril—hypertension	0.000148	0.000991	CcSEcCtD
Flavoxate—Tachycardia—Captopril—hypertension	0.000148	0.000989	CcSEcCtD
Flavoxate—Nausea—Acebutolol—hypertension	0.000147	0.000984	CcSEcCtD
Flavoxate—Vomiting—Amlodipine—hypertension	0.000147	0.000981	CcSEcCtD
Flavoxate—Confusional state—Hydrochlorothiazide—hypertension	0.000147	0.000981	CcSEcCtD
Flavoxate—Urticaria—Nifedipine—hypertension	0.000146	0.000978	CcSEcCtD
Flavoxate—Dry mouth—Furosemide—hypertension	0.000146	0.000976	CcSEcCtD
Flavoxate—Nausea—Labetalol—hypertension	0.000146	0.000975	CcSEcCtD
Flavoxate—Urticaria—Verapamil—hypertension	0.000146	0.000973	CcSEcCtD
Flavoxate—Headache—Nisoldipine—hypertension	0.000145	0.000967	CcSEcCtD
Flavoxate—Headache—Amlodipine—hypertension	0.000145	0.000967	CcSEcCtD
Flavoxate—Somnolence—Clonidine—hypertension	0.000145	0.000967	CcSEcCtD
Flavoxate—Dry mouth—Betaxolol—hypertension	0.000145	0.000966	CcSEcCtD
Flavoxate—Confusional state—Furosemide—hypertension	0.000144	0.000964	CcSEcCtD
Flavoxate—Tachycardia—Perindopril—hypertension	0.000144	0.00096	CcSEcCtD
Flavoxate—Tachycardia—Irbesartan—hypertension	0.000143	0.000957	CcSEcCtD
Flavoxate—Skin disorder—Perindopril—hypertension	0.000143	0.000956	CcSEcCtD
Flavoxate—Confusional state—Betaxolol—hypertension	0.000143	0.000955	CcSEcCtD
Flavoxate—Skin disorder—Irbesartan—hypertension	0.000143	0.000952	CcSEcCtD
Flavoxate—Tension—Ramipril—hypertension	0.000143	0.000951	CcSEcCtD
Flavoxate—Tachycardia—Hydrochlorothiazide—hypertension	0.000142	0.000949	CcSEcCtD
Flavoxate—Nausea—Eprosartan—hypertension	0.000141	0.000944	CcSEcCtD
Flavoxate—Somnolence—Trandolapril—hypertension	0.000141	0.000943	CcSEcCtD
Flavoxate—Nervousness—Ramipril—hypertension	0.000141	0.000942	CcSEcCtD
Flavoxate—Dry mouth—Losartan—hypertension	0.000141	0.000941	CcSEcCtD
Flavoxate—Somnolence—Enalapril—hypertension	0.000141	0.000939	CcSEcCtD
Flavoxate—Feeling abnormal—Olmesartan—hypertension	0.00014	0.000936	CcSEcCtD
Flavoxate—Confusional state—Losartan—hypertension	0.000139	0.00093	CcSEcCtD
Flavoxate—Tension—Timolol—hypertension	0.000139	0.00093	CcSEcCtD
Flavoxate—Skin disorder—Furosemide—hypertension	0.000139	0.000929	CcSEcCtD
Flavoxate—Somnolence—Telmisartan—hypertension	0.000139	0.000926	CcSEcCtD
Flavoxate—Tachycardia—Betaxolol—hypertension	0.000138	0.000924	CcSEcCtD
Flavoxate—Vomiting—Guanabenz—hypertension	0.000138	0.000922	CcSEcCtD
Flavoxate—Vomiting—Metoprolol—hypertension	0.000138	0.000922	CcSEcCtD
Flavoxate—Nervousness—Timolol—hypertension	0.000138	0.00092	CcSEcCtD
Flavoxate—Skin disorder—Betaxolol—hypertension	0.000138	0.00092	CcSEcCtD
Flavoxate—Nausea—Amlodipine—hypertension	0.000137	0.000917	CcSEcCtD
Flavoxate—Nausea—Nisoldipine—hypertension	0.000137	0.000917	CcSEcCtD
Flavoxate—Headache—Guanabenz—hypertension	0.000136	0.000909	CcSEcCtD
Flavoxate—Headache—Metoprolol—hypertension	0.000136	0.000909	CcSEcCtD
Flavoxate—Urticaria—Valsartan—hypertension	0.000136	0.000906	CcSEcCtD
Flavoxate—Urticaria—Olmesartan—hypertension	0.000135	0.000902	CcSEcCtD
Flavoxate—Somnolence—Captopril—hypertension	0.000135	0.000901	CcSEcCtD
Flavoxate—Tachycardia—Losartan—hypertension	0.000135	0.000901	CcSEcCtD
Flavoxate—Feeling abnormal—Clonidine—hypertension	0.000134	0.000896	CcSEcCtD
Flavoxate—Vision blurred—Timolol—hypertension	0.000134	0.000893	CcSEcCtD
Flavoxate—Somnolence—Perindopril—hypertension	0.000131	0.000875	CcSEcCtD
Flavoxate—Feeling abnormal—Trandolapril—hypertension	0.000131	0.000874	CcSEcCtD
Flavoxate—Somnolence—Irbesartan—hypertension	0.000131	0.000872	CcSEcCtD
Flavoxate—Vertigo—Ramipril—hypertension	0.00013	0.000871	CcSEcCtD
Flavoxate—Feeling abnormal—Enalapril—hypertension	0.00013	0.000871	CcSEcCtD
Flavoxate—Leukopenia—Ramipril—hypertension	0.00013	0.000868	CcSEcCtD
Flavoxate—Somnolence—Hydrochlorothiazide—hypertension	0.00013	0.000864	CcSEcCtD
Flavoxate—Urticaria—Clonidine—hypertension	0.000129	0.000864	CcSEcCtD
Flavoxate—Tension—Lisinopril—hypertension	0.000129	0.000863	CcSEcCtD
Flavoxate—Nausea—Guanabenz—hypertension	0.000129	0.000862	CcSEcCtD
Flavoxate—Nausea—Metoprolol—hypertension	0.000129	0.000862	CcSEcCtD
Flavoxate—Feeling abnormal—Telmisartan—hypertension	0.000129	0.000859	CcSEcCtD
Flavoxate—Palpitations—Ramipril—hypertension	0.000128	0.000857	CcSEcCtD
Flavoxate—Nervousness—Lisinopril—hypertension	0.000128	0.000854	CcSEcCtD
Flavoxate—Vertigo—Timolol—hypertension	0.000128	0.000851	CcSEcCtD
Flavoxate—Somnolence—Furosemide—hypertension	0.000127	0.00085	CcSEcCtD
Flavoxate—Vomiting—Propranolol—hypertension	0.000127	0.000847	CcSEcCtD
Flavoxate—Urticaria—Trandolapril—hypertension	0.000126	0.000843	CcSEcCtD
Flavoxate—Urticaria—Enalapril—hypertension	0.000126	0.000839	CcSEcCtD
Flavoxate—Palpitations—Timolol—hypertension	0.000125	0.000838	CcSEcCtD
Flavoxate—Feeling abnormal—Captopril—hypertension	0.000125	0.000835	CcSEcCtD
Flavoxate—Vision blurred—Lisinopril—hypertension	0.000124	0.000829	CcSEcCtD
Flavoxate—Urticaria—Telmisartan—hypertension	0.000124	0.000828	CcSEcCtD
Flavoxate—Somnolence—Losartan—hypertension	0.000123	0.00082	CcSEcCtD
Flavoxate—Vomiting—Indapamide—hypertension	0.000123	0.00082	CcSEcCtD
Flavoxate—Vomiting—Diltiazem—hypertension	0.000123	0.00082	CcSEcCtD
Flavoxate—Vomiting—Carvedilol—hypertension	0.000122	0.000812	CcSEcCtD
Flavoxate—Feeling abnormal—Perindopril—hypertension	0.000121	0.000811	CcSEcCtD
Flavoxate—Feeling abnormal—Irbesartan—hypertension	0.000121	0.000808	CcSEcCtD
Flavoxate—Headache—Indapamide—hypertension	0.000121	0.000808	CcSEcCtD
Flavoxate—Headache—Diltiazem—hypertension	0.000121	0.000808	CcSEcCtD
Flavoxate—Dry mouth—Ramipril—hypertension	0.000121	0.000807	CcSEcCtD
Flavoxate—Vomiting—Doxazosin—hypertension	0.00012	0.000803	CcSEcCtD
Flavoxate—Feeling abnormal—Hydrochlorothiazide—hypertension	0.00012	0.000801	CcSEcCtD
Flavoxate—Headache—Carvedilol—hypertension	0.00012	0.0008	CcSEcCtD
Flavoxate—Confusional state—Ramipril—hypertension	0.00012	0.000798	CcSEcCtD
Flavoxate—Vomiting—Fosinopril—hypertension	0.000119	0.000793	CcSEcCtD
Flavoxate—Nausea—Propranolol—hypertension	0.000119	0.000791	CcSEcCtD
Flavoxate—Headache—Doxazosin—hypertension	0.000119	0.000791	CcSEcCtD
Flavoxate—Vertigo—Lisinopril—hypertension	0.000118	0.00079	CcSEcCtD
Flavoxate—Dry mouth—Timolol—hypertension	0.000118	0.000789	CcSEcCtD
Flavoxate—Vomiting—Eplerenone—hypertension	0.000118	0.000788	CcSEcCtD
Flavoxate—Feeling abnormal—Furosemide—hypertension	0.000118	0.000788	CcSEcCtD
Flavoxate—Leukopenia—Lisinopril—hypertension	0.000118	0.000787	CcSEcCtD
Flavoxate—Vomiting—Nifedipine—hypertension	0.000117	0.000783	CcSEcCtD
Flavoxate—Urticaria—Perindopril—hypertension	0.000117	0.000781	CcSEcCtD
Flavoxate—Headache—Fosinopril—hypertension	0.000117	0.000781	CcSEcCtD
Flavoxate—Feeling abnormal—Betaxolol—hypertension	0.000117	0.00078	CcSEcCtD
Flavoxate—Confusional state—Timolol—hypertension	0.000117	0.00078	CcSEcCtD
Flavoxate—Vomiting—Verapamil—hypertension	0.000117	0.000779	CcSEcCtD
Flavoxate—Urticaria—Irbesartan—hypertension	0.000117	0.000779	CcSEcCtD
Flavoxate—Palpitations—Lisinopril—hypertension	0.000116	0.000777	CcSEcCtD
Flavoxate—Headache—Eplerenone—hypertension	0.000116	0.000777	CcSEcCtD
Flavoxate—Urticaria—Hydrochlorothiazide—hypertension	0.000116	0.000773	CcSEcCtD
Flavoxate—Tachycardia—Ramipril—hypertension	0.000116	0.000772	CcSEcCtD
Flavoxate—Headache—Nifedipine—hypertension	0.000116	0.000771	CcSEcCtD
Flavoxate—Skin disorder—Ramipril—hypertension	0.000115	0.000768	CcSEcCtD
Flavoxate—Headache—Verapamil—hypertension	0.000115	0.000768	CcSEcCtD
Flavoxate—Nausea—Indapamide—hypertension	0.000115	0.000766	CcSEcCtD
Flavoxate—Nausea—Diltiazem—hypertension	0.000115	0.000766	CcSEcCtD
Flavoxate—Feeling abnormal—Losartan—hypertension	0.000114	0.00076	CcSEcCtD
Flavoxate—Urticaria—Furosemide—hypertension	0.000114	0.00076	CcSEcCtD
Flavoxate—Nausea—Carvedilol—hypertension	0.000114	0.000758	CcSEcCtD
Flavoxate—Urticaria—Betaxolol—hypertension	0.000113	0.000752	CcSEcCtD
Flavoxate—Skin disorder—Timolol—hypertension	0.000113	0.000751	CcSEcCtD
Flavoxate—Nausea—Doxazosin—hypertension	0.000112	0.00075	CcSEcCtD
Flavoxate—Nausea—Fosinopril—hypertension	0.000111	0.000741	CcSEcCtD
Flavoxate—Nausea—Eplerenone—hypertension	0.00011	0.000736	CcSEcCtD
Flavoxate—Urticaria—Losartan—hypertension	0.00011	0.000733	CcSEcCtD
Flavoxate—Dry mouth—Lisinopril—hypertension	0.00011	0.000732	CcSEcCtD
Flavoxate—Nausea—Nifedipine—hypertension	0.00011	0.000731	CcSEcCtD
Flavoxate—Nausea—Verapamil—hypertension	0.000109	0.000728	CcSEcCtD
Flavoxate—Vomiting—Valsartan—hypertension	0.000109	0.000725	CcSEcCtD
Flavoxate—Confusional state—Lisinopril—hypertension	0.000108	0.000723	CcSEcCtD
Flavoxate—Vomiting—Olmesartan—hypertension	0.000108	0.000722	CcSEcCtD
Flavoxate—Headache—Valsartan—hypertension	0.000107	0.000715	CcSEcCtD
Flavoxate—Headache—Olmesartan—hypertension	0.000107	0.000711	CcSEcCtD
Flavoxate—Somnolence—Ramipril—hypertension	0.000105	0.000703	CcSEcCtD
Flavoxate—Tachycardia—Lisinopril—hypertension	0.000105	0.0007	CcSEcCtD
Flavoxate—Skin disorder—Lisinopril—hypertension	0.000104	0.000697	CcSEcCtD
Flavoxate—Vomiting—Clonidine—hypertension	0.000104	0.000691	CcSEcCtD
Flavoxate—Somnolence—Timolol—hypertension	0.000103	0.000688	CcSEcCtD
Flavoxate—Headache—Clonidine—hypertension	0.000102	0.000681	CcSEcCtD
Flavoxate—Nausea—Valsartan—hypertension	0.000102	0.000678	CcSEcCtD
Flavoxate—Nausea—Olmesartan—hypertension	0.000101	0.000674	CcSEcCtD
Flavoxate—Vomiting—Trandolapril—hypertension	0.000101	0.000674	CcSEcCtD
Flavoxate—Vomiting—Enalapril—hypertension	0.000101	0.000672	CcSEcCtD
Flavoxate—Headache—Trandolapril—hypertension	9.95e-05	0.000664	CcSEcCtD
Flavoxate—Vomiting—Telmisartan—hypertension	9.93e-05	0.000662	CcSEcCtD
Flavoxate—Headache—Enalapril—hypertension	9.91e-05	0.000662	CcSEcCtD
Flavoxate—Headache—Telmisartan—hypertension	9.78e-05	0.000653	CcSEcCtD
Flavoxate—Feeling abnormal—Ramipril—hypertension	9.77e-05	0.000652	CcSEcCtD
Flavoxate—Nausea—Clonidine—hypertension	9.68e-05	0.000646	CcSEcCtD
Flavoxate—Vomiting—Captopril—hypertension	9.65e-05	0.000644	CcSEcCtD
Flavoxate—Somnolence—Lisinopril—hypertension	9.56e-05	0.000638	CcSEcCtD
Flavoxate—Feeling abnormal—Timolol—hypertension	9.55e-05	0.000637	CcSEcCtD
Flavoxate—Headache—Captopril—hypertension	9.51e-05	0.000635	CcSEcCtD
Flavoxate—Nausea—Trandolapril—hypertension	9.44e-05	0.00063	CcSEcCtD
Flavoxate—Urticaria—Ramipril—hypertension	9.42e-05	0.000629	CcSEcCtD
Flavoxate—Nausea—Enalapril—hypertension	9.4e-05	0.000627	CcSEcCtD
Flavoxate—Vomiting—Perindopril—hypertension	9.37e-05	0.000625	CcSEcCtD
Flavoxate—Vomiting—Irbesartan—hypertension	9.34e-05	0.000623	CcSEcCtD
Flavoxate—Nausea—Telmisartan—hypertension	9.27e-05	0.000619	CcSEcCtD
Flavoxate—Vomiting—Hydrochlorothiazide—hypertension	9.26e-05	0.000618	CcSEcCtD
Flavoxate—Headache—Perindopril—hypertension	9.23e-05	0.000616	CcSEcCtD
Flavoxate—Urticaria—Timolol—hypertension	9.21e-05	0.000614	CcSEcCtD
Flavoxate—Headache—Irbesartan—hypertension	9.2e-05	0.000614	CcSEcCtD
Flavoxate—Headache—Hydrochlorothiazide—hypertension	9.13e-05	0.000609	CcSEcCtD
Flavoxate—Vomiting—Furosemide—hypertension	9.11e-05	0.000608	CcSEcCtD
Flavoxate—Vomiting—Betaxolol—hypertension	9.02e-05	0.000602	CcSEcCtD
Flavoxate—Nausea—Captopril—hypertension	9.02e-05	0.000602	CcSEcCtD
Flavoxate—Headache—Furosemide—hypertension	8.98e-05	0.000599	CcSEcCtD
Flavoxate—Headache—Betaxolol—hypertension	8.89e-05	0.000593	CcSEcCtD
Flavoxate—Feeling abnormal—Lisinopril—hypertension	8.86e-05	0.000591	CcSEcCtD
Flavoxate—Vomiting—Losartan—hypertension	8.79e-05	0.000587	CcSEcCtD
Flavoxate—Nausea—Perindopril—hypertension	8.75e-05	0.000584	CcSEcCtD
Flavoxate—Nausea—Irbesartan—hypertension	8.73e-05	0.000582	CcSEcCtD
Flavoxate—Headache—Losartan—hypertension	8.66e-05	0.000578	CcSEcCtD
Flavoxate—Nausea—Hydrochlorothiazide—hypertension	8.65e-05	0.000578	CcSEcCtD
Flavoxate—Urticaria—Lisinopril—hypertension	8.54e-05	0.00057	CcSEcCtD
Flavoxate—Nausea—Furosemide—hypertension	8.51e-05	0.000568	CcSEcCtD
Flavoxate—Nausea—Betaxolol—hypertension	8.43e-05	0.000562	CcSEcCtD
Flavoxate—Nausea—Losartan—hypertension	8.21e-05	0.000548	CcSEcCtD
Flavoxate—Vomiting—Ramipril—hypertension	7.54e-05	0.000503	CcSEcCtD
Flavoxate—Headache—Ramipril—hypertension	7.43e-05	0.000496	CcSEcCtD
Flavoxate—Vomiting—Timolol—hypertension	7.37e-05	0.000492	CcSEcCtD
Flavoxate—Headache—Timolol—hypertension	7.26e-05	0.000485	CcSEcCtD
Flavoxate—Nausea—Ramipril—hypertension	7.04e-05	0.00047	CcSEcCtD
Flavoxate—Nausea—Timolol—hypertension	6.88e-05	0.000459	CcSEcCtD
Flavoxate—Vomiting—Lisinopril—hypertension	6.84e-05	0.000456	CcSEcCtD
Flavoxate—Headache—Lisinopril—hypertension	6.73e-05	0.00045	CcSEcCtD
Flavoxate—Nausea—Lisinopril—hypertension	6.39e-05	0.000426	CcSEcCtD
Flavoxate—CHRM2—Signaling Pathways—BDKRB2—hypertension	3.03e-06	2.08e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—POMC—hypertension	3.02e-06	2.08e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—PTEN—hypertension	3.02e-06	2.07e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—F2—hypertension	3.02e-06	2.07e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PRKCB—hypertension	3.02e-06	2.07e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CNR1—hypertension	3.01e-06	2.07e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRBK1—hypertension	3e-06	2.06e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CALM2—hypertension	2.98e-06	2.05e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CNR1—hypertension	2.97e-06	2.04e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CXCL8—hypertension	2.96e-06	2.03e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MAPK8—hypertension	2.96e-06	2.03e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling by GPCR—AKT1—hypertension	2.95e-06	2.02e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AKT2—hypertension	2.95e-06	2.02e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CALM2—hypertension	2.94e-06	2.02e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—DRD2—hypertension	2.94e-06	2.02e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR7—hypertension	2.94e-06	2.02e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GCG—hypertension	2.91e-06	2e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTPN1—hypertension	2.91e-06	2e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AKT2—hypertension	2.91e-06	2e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—DRD2—hypertension	2.9e-06	1.99e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR7—hypertension	2.9e-06	1.99e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MMP9—hypertension	2.89e-06	1.99e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—MYC—hypertension	2.89e-06	1.98e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—CDKN1A—hypertension	2.88e-06	1.98e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EP300—hypertension	2.88e-06	1.98e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TGFB1—hypertension	2.88e-06	1.98e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—PTEN—hypertension	2.88e-06	1.97e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTPN1—hypertension	2.87e-06	1.97e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GCG—hypertension	2.87e-06	1.97e-05	CbGpPWpGaD
Flavoxate—PDE4B—GPCR downstream signaling—AKT1—hypertension	2.86e-06	1.96e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KL—hypertension	2.85e-06	1.96e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH2—hypertension	2.85e-06	1.96e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—EGFR—hypertension	2.82e-06	1.94e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KL—hypertension	2.82e-06	1.93e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH2—hypertension	2.82e-06	1.93e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—IL6—hypertension	2.82e-06	1.93e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MAPK8—hypertension	2.81e-06	1.93e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling by GPCR—AKT1—hypertension	2.81e-06	1.93e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—SRC—hypertension	2.8e-06	1.92e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ITGAV—hypertension	2.8e-06	1.92e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NGFR—hypertension	2.8e-06	1.92e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KNG1—hypertension	2.79e-06	1.92e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—POMC—hypertension	2.78e-06	1.91e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRL—hypertension	2.77e-06	1.9e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AGTR1—hypertension	2.77e-06	1.9e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NGFR—hypertension	2.76e-06	1.9e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ITGAV—hypertension	2.76e-06	1.9e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KNG1—hypertension	2.76e-06	1.89e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—POMC—hypertension	2.75e-06	1.89e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EP300—hypertension	2.74e-06	1.88e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AGTR1—hypertension	2.74e-06	1.88e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRL—hypertension	2.74e-06	1.88e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HDAC1—hypertension	2.73e-06	1.88e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—STK11—hypertension	2.73e-06	1.88e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—VEGFA—hypertension	2.73e-06	1.87e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CCL2—hypertension	2.72e-06	1.87e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL10—hypertension	2.71e-06	1.86e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PLG—hypertension	2.7e-06	1.86e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—RHOA—hypertension	2.7e-06	1.85e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—STK11—hypertension	2.7e-06	1.85e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HDAC1—hypertension	2.7e-06	1.85e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CCL2—hypertension	2.69e-06	1.84e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MMP9—hypertension	2.68e-06	1.84e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL10—hypertension	2.68e-06	1.84e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKT2—hypertension	2.67e-06	1.84e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—PIK3R1—hypertension	2.67e-06	1.83e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PLG—hypertension	2.67e-06	1.83e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—CDKN1A—hypertension	2.67e-06	1.83e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—SRC—hypertension	2.67e-06	1.83e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—RHOA—hypertension	2.67e-06	1.83e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—PTEN—hypertension	2.66e-06	1.83e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKT2—hypertension	2.64e-06	1.81e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—PIK3R1—hypertension	2.64e-06	1.81e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADRB2—hypertension	2.63e-06	1.81e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MAPK8—hypertension	2.6e-06	1.79e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRKCE—hypertension	2.6e-06	1.78e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADRB2—hypertension	2.6e-06	1.78e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—VEGFA—hypertension	2.6e-06	1.78e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling by GPCR—AKT1—hypertension	2.6e-06	1.78e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDGFA—hypertension	2.57e-06	1.76e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VAV3—hypertension	2.57e-06	1.76e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRKCE—hypertension	2.57e-06	1.76e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EP300—hypertension	2.54e-06	1.74e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDGFA—hypertension	2.53e-06	1.74e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VAV3—hypertension	2.53e-06	1.74e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFBR2—hypertension	2.53e-06	1.74e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—MYC—hypertension	2.51e-06	1.72e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GNB3—hypertension	2.51e-06	1.72e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TGFB1—hypertension	2.51e-06	1.72e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFBR2—hypertension	2.5e-06	1.71e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GNB3—hypertension	2.47e-06	1.7e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AVP—hypertension	2.47e-06	1.7e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—SRC—hypertension	2.47e-06	1.69e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—EGFR—hypertension	2.46e-06	1.69e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—RHOA—hypertension	2.45e-06	1.68e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AVP—hypertension	2.44e-06	1.68e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—GNAS—hypertension	2.44e-06	1.68e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—PIK3R1—hypertension	2.43e-06	1.67e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—RHOA—hypertension	2.42e-06	1.66e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—GNAS—hypertension	2.41e-06	1.65e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—VEGFA—hypertension	2.4e-06	1.65e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—PIK3R1—hypertension	2.4e-06	1.64e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—MYC—hypertension	2.39e-06	1.64e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOB—hypertension	2.39e-06	1.64e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TGFB1—hypertension	2.39e-06	1.64e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTK2—hypertension	2.38e-06	1.63e-05	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—CXCL8—hypertension	2.37e-06	1.63e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—TP53—hypertension	2.37e-06	1.63e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOB—hypertension	2.36e-06	1.62e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EDN1—hypertension	2.35e-06	1.61e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTK2—hypertension	2.35e-06	1.61e-05	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—CXCL8—hypertension	2.34e-06	1.61e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—EGFR—hypertension	2.34e-06	1.61e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL5—hypertension	2.33e-06	1.6e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EDN1—hypertension	2.32e-06	1.59e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL5—hypertension	2.3e-06	1.58e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LPL—hypertension	2.28e-06	1.57e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—H2AFX—hypertension	2.27e-06	1.56e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDGFRB—hypertension	2.26e-06	1.55e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RPS6KB1—hypertension	2.26e-06	1.55e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LPL—hypertension	2.25e-06	1.55e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—H2AFX—hypertension	2.24e-06	1.54e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ADCY5—hypertension	2.23e-06	1.53e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDGFRB—hypertension	2.23e-06	1.53e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RPS6KB1—hypertension	2.23e-06	1.53e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRKCG—hypertension	2.22e-06	1.52e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—MYC—hypertension	2.21e-06	1.52e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TGFB1—hypertension	2.21e-06	1.51e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ADCY5—hypertension	2.21e-06	1.51e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—ITGB3—hypertension	2.2e-06	1.51e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRKCA—hypertension	2.2e-06	1.51e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRKCG—hypertension	2.19e-06	1.5e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—YWHAZ—hypertension	2.19e-06	1.5e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRKCA—hypertension	2.18e-06	1.49e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—ITGB3—hypertension	2.18e-06	1.49e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—IL6—hypertension	2.17e-06	1.49e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—EGFR—hypertension	2.16e-06	1.49e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NGF—hypertension	2.16e-06	1.48e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SPP1—hypertension	2.16e-06	1.48e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—YWHAZ—hypertension	2.16e-06	1.48e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—CXCL8—hypertension	2.15e-06	1.48e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NGF—hypertension	2.13e-06	1.46e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SPP1—hypertension	2.13e-06	1.46e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—CXCL8—hypertension	2.12e-06	1.46e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRKCD—hypertension	2.1e-06	1.44e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCR5—hypertension	2.1e-06	1.44e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCR5—hypertension	2.08e-06	1.42e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRKCD—hypertension	2.08e-06	1.42e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—TP53—hypertension	2.06e-06	1.42e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HTR2A—hypertension	2.06e-06	1.41e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—C3—hypertension	2.06e-06	1.41e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HTR2A—hypertension	2.03e-06	1.39e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—C3—hypertension	2.03e-06	1.39e-05	CbGpPWpGaD
Flavoxate—PDE4C—Signaling Pathways—AKT1—hypertension	2e-06	1.37e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PDGFB—hypertension	2e-06	1.37e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGFR1—hypertension	1.99e-06	1.37e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PDGFB—hypertension	1.97e-06	1.36e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGFR1—hypertension	1.96e-06	1.35e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—TP53—hypertension	1.96e-06	1.35e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—HIF1A—hypertension	1.96e-06	1.35e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AGT—hypertension	1.95e-06	1.34e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—HIF1A—hypertension	1.93e-06	1.33e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AGT—hypertension	1.93e-06	1.32e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CALM1—hypertension	1.92e-06	1.32e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—LEP—hypertension	1.91e-06	1.31e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOE—hypertension	1.91e-06	1.31e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CAV1—hypertension	1.9e-06	1.3e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CALM1—hypertension	1.9e-06	1.3e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—APOA1—hypertension	1.89e-06	1.3e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOE—hypertension	1.89e-06	1.3e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—LEP—hypertension	1.89e-06	1.3e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—IL6—hypertension	1.89e-06	1.3e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—KDR—hypertension	1.87e-06	1.29e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CAV1—hypertension	1.87e-06	1.28e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—APOA1—hypertension	1.87e-06	1.28e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—KDR—hypertension	1.85e-06	1.27e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—TP53—hypertension	1.82e-06	1.25e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FN1—hypertension	1.8e-06	1.24e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—F2—hypertension	1.8e-06	1.24e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PRKCB—hypertension	1.8e-06	1.24e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—IL6—hypertension	1.8e-06	1.23e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PRKCB—hypertension	1.78e-06	1.22e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—F2—hypertension	1.78e-06	1.22e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FN1—hypertension	1.78e-06	1.22e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOTCH1—hypertension	1.77e-06	1.21e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOTCH1—hypertension	1.74e-06	1.2e-05	CbGpPWpGaD
Flavoxate—PDE4D—Signaling Pathways—AKT1—hypertension	1.74e-06	1.2e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—IL6—hypertension	1.66e-06	1.14e-05	CbGpPWpGaD
Flavoxate—PDE4A—Signaling Pathways—AKT1—hypertension	1.66e-06	1.14e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—POMC—hypertension	1.64e-06	1.13e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—INS—hypertension	1.63e-06	1.12e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—POMC—hypertension	1.62e-06	1.11e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—INS—hypertension	1.61e-06	1.11e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CCL2—hypertension	1.61e-06	1.1e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CCL2—hypertension	1.59e-06	1.09e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IGF1—hypertension	1.58e-06	1.09e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKT2—hypertension	1.58e-06	1.08e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—EGFR—hypertension	1.57e-06	1.08e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IGF1—hypertension	1.56e-06	1.07e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKT2—hypertension	1.56e-06	1.07e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—EGFR—hypertension	1.55e-06	1.07e-05	CbGpPWpGaD
Flavoxate—PDE4B—Signaling Pathways—AKT1—hypertension	1.53e-06	1.05e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SERPINE1—hypertension	1.5e-06	1.03e-05	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SERPINE1—hypertension	1.48e-06	1.02e-05	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—FGF2—hypertension	1.45e-06	9.98e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RHOA—hypertension	1.45e-06	9.94e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—FGF2—hypertension	1.43e-06	9.85e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PIK3R1—hypertension	1.43e-06	9.84e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—NOS3—hypertension	1.43e-06	9.84e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RHOA—hypertension	1.43e-06	9.81e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PIK3R1—hypertension	1.41e-06	9.71e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—NOS3—hypertension	1.41e-06	9.71e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—RELA—hypertension	1.35e-06	9.26e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—RELA—hypertension	1.33e-06	9.14e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MTOR—hypertension	1.32e-06	9.08e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MTOR—hypertension	1.31e-06	8.96e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CXCL8—hypertension	1.27e-06	8.73e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CXCL8—hypertension	1.26e-06	8.61e-06	CbGpPWpGaD
Flavoxate—CHRM1—GPCR downstream signaling—AKT1—hypertension	1.23e-06	8.43e-06	CbGpPWpGaD
Flavoxate—CHRM2—GPCR downstream signaling—AKT1—hypertension	1.21e-06	8.32e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—IL6—hypertension	1.21e-06	8.3e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—IL6—hypertension	1.19e-06	8.19e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MMP9—hypertension	1.15e-06	7.89e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—CDKN1A—hypertension	1.15e-06	7.87e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—PTEN—hypertension	1.14e-06	7.85e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MMP9—hypertension	1.14e-06	7.79e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—CDKN1A—hypertension	1.13e-06	7.76e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—PTEN—hypertension	1.13e-06	7.75e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MAPK8—hypertension	1.12e-06	7.68e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling by GPCR—AKT1—hypertension	1.12e-06	7.66e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MAPK8—hypertension	1.1e-06	7.58e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling by GPCR—AKT1—hypertension	1.1e-06	7.56e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EP300—hypertension	1.09e-06	7.48e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EP300—hypertension	1.08e-06	7.39e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—SRC—hypertension	1.06e-06	7.28e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—SRC—hypertension	1.05e-06	7.18e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—VEGFA—hypertension	1.03e-06	7.09e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—VEGFA—hypertension	1.02e-06	7e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—MYC—hypertension	9.5e-07	6.52e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TGFB1—hypertension	9.48e-07	6.51e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—MYC—hypertension	9.38e-07	6.44e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TGFB1—hypertension	9.36e-07	6.42e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—EGFR—hypertension	9.29e-07	6.38e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—EGFR—hypertension	9.17e-07	6.3e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—TP53—hypertension	7.8e-07	5.36e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—TP53—hypertension	7.7e-07	5.29e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—IL6—hypertension	7.14e-07	4.9e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—IL6—hypertension	7.05e-07	4.84e-06	CbGpPWpGaD
Flavoxate—CHRM1—Signaling Pathways—AKT1—hypertension	6.59e-07	4.52e-06	CbGpPWpGaD
Flavoxate—CHRM2—Signaling Pathways—AKT1—hypertension	6.5e-07	4.46e-06	CbGpPWpGaD
